KURA ONCOLOGY, INC. Increase (Decrease) in Other Noncurrent Assets
KURA ONCOLOGY, INC. (KURA) reported Increase (Decrease) in Other Noncurrent Assets of -$226.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2022-11-03
- KURA ONCOLOGY, INC. increase (decrease) in other noncurrent assets for the quarter ending 2022-09-30 was -$231.00K.
- KURA ONCOLOGY, INC. increase (decrease) in other noncurrent assets for the quarter ending 2022-06-30 was $110.00K, a 93.07% decline year-over-year.
- KURA ONCOLOGY, INC. increase (decrease) in other noncurrent assets for the quarter ending 2022-03-31 was -$105.00K.
- KURA ONCOLOGY, INC. increase (decrease) in other noncurrent assets for the quarter ending 2021-12-31 was -$417.00K.
- KURA ONCOLOGY, INC. increase (decrease) in other noncurrent assets for fiscal 2021 was $329.00K.
- KURA ONCOLOGY, INC. increase (decrease) in other noncurrent assets for fiscal 2020 was -$1.21M, a 1129.91% decline from fiscal 2019.
- KURA ONCOLOGY, INC. increase (decrease) in other noncurrent assets for fiscal 2019 was $117.00K, a 76.79% decline from fiscal 2018.
- KURA ONCOLOGY, INC. increase (decrease) in other noncurrent assets for fiscal 2018 was $504.00K, a 15.01% decline from fiscal 2017.
| Period end | Increase (Decrease) in Other Noncurrent Assets 1 month | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 3 month as first filed | Increase (Decrease) in Other Noncurrent Assets 4 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 6 month as first filed | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 9 month as first filed | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | -$231.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$121.00K derived: sum of 2 quarters · filed 2022-11-03 | -$226.00K 10-Q · filed 2022-11-03 | -$643.00K derived: sum of 4 quarters · filed 2022-11-03 | |||||
| 2022-06-30 | $110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $5.00K 10-Q · filed 2022-08-03 | -$412.00K derived: sum of 3 quarters · filed 2022-08-03 | -$844.00K derived: sum of 4 quarters · filed 2022-11-03 | |||||
| 2022-03-31 | -$105.00K 10-Q · filed 2022-05-04 | -$522.00K derived: sum of 2 quarters · filed 2022-05-04 | -$954.00K derived: sum of 3 quarters · filed 2022-11-03 | $634.00K derived: sum of 4 quarters · filed 2022-11-03 | |||||
| 2021-12-31 | -$417.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$849.00K derived: sum of 2 quarters · filed 2022-11-03 | $739.00K derived: sum of 3 quarters · filed 2022-11-03 | $329.00K 10-K · filed 2022-02-24 | |||||
| 2021-09-30 | -$432.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.16M derived: sum of 2 quarters · filed 2022-11-03 | $746.00K 10-Q · filed 2022-11-03 | $373.00K derived: sum of 4 quarters · filed 2022-11-03 | |||||
| 2021-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $1.18M 10-Q · filed 2022-08-03 | $805.00K derived: sum of 3 quarters · filed 2022-08-03 | $506.00K derived: sum of 4 quarters · filed 2022-08-03 | |||||
| 2021-03-31 | -$410.00K 10-Q · filed 2022-05-04 | -$783.00K derived: sum of 2 quarters · filed 2022-05-04 | -$1.08M derived: sum of 3 quarters · filed 2022-05-04 | -$1.46M derived: sum of 4 quarters · filed 2022-05-04 | |||||
| 2020-12-31 | -$373.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$672.00K derived: sum of 2 quarters · filed 2022-02-24 | -$1.04M derived: sum of 3 quarters · filed 2022-02-24 | -$1.21M 10-K · filed 2022-02-24 | |||||
| 2020-09-30 | -$299.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$672.00K derived: sum of 2 quarters · filed 2021-11-04 | -$832.00K 10-Q · filed 2021-11-04 | -$802.00K derived: sum of 4 quarters · filed 2022-02-24 | |||||
| 2020-06-30 | -$373.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$533.00K 10-Q · filed 2021-08-05 | -$503.00K derived: sum of 3 quarters · filed 2022-02-24 | -$631.00K derived: sum of 4 quarters · filed 2022-02-24 | |||||
| 2020-03-31 | -$160.00K 10-Q · filed 2021-05-06 | -$130.00K derived: sum of 2 quarters · filed 2022-02-24 | -$258.00K derived: sum of 3 quarters · filed 2022-02-24 | -$225.00K derived: sum of 4 quarters · filed 2022-02-24 | |||||
| 2019-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$98.00K derived: sum of 2 quarters · filed 2022-02-24 | -$65.00K derived: sum of 3 quarters · filed 2022-02-24 | $117.00K 10-K · filed 2022-02-24 | |||||
| 2019-09-30 | -$128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$95.00K derived: sum of 2 quarters · filed 2020-11-05 | $87.00K 10-Q · filed 2020-11-05 | $250.00K 10-Q · filed 2019-11-05 | $236.00K derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $215.00K 10-Q · filed 2020-08-06 | $321.00K 10-Q · filed 2019-08-01 | $364.00K derived: sum of 3 quarters · filed 2021-02-24 | $677.00K derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2019-03-31 | $182.00K 10-Q · filed 2020-05-04 | $239.00K 10-Q · filed 2019-05-07 | $331.00K derived: sum of 2 quarters · filed 2021-02-24 | $644.00K derived: sum of 3 quarters · filed 2021-02-24 | $523.00K derived: sum of 4 quarters · filed 2021-02-24 | ||||
| 2018-12-31 | $149.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $462.00K derived: sum of 2 quarters · filed 2021-02-24 | $341.00K derived: sum of 3 quarters · filed 2021-02-24 | $504.00K 10-K · filed 2021-02-24 | |||||
| 2018-09-30 | $313.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $192.00K derived: sum of 2 quarters · filed 2019-11-05 | $355.00K 10-Q · filed 2019-11-05 | $743.00K derived: sum of 4 quarters · filed 2020-02-25 | |||||
| 2018-06-30 | -$121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $42.00K 10-Q · filed 2019-08-01 | $430.00K derived: sum of 3 quarters · filed 2020-02-25 | $518.00K derived: sum of 4 quarters · filed 2020-02-25 | |||||
| 2018-03-31 | $163.00K 10-Q · filed 2019-05-07 | $551.00K derived: sum of 2 quarters · filed 2020-02-25 | $639.00K derived: sum of 3 quarters · filed 2020-02-25 | $468.00K derived: sum of 4 quarters · filed 2020-02-25 | |||||
| 2017-12-31 | $388.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $476.00K derived: sum of 2 quarters · filed 2020-02-25 | $305.00K derived: sum of 3 quarters · filed 2020-02-25 | $593.00K 10-K · filed 2020-02-25 | |||||
| 2017-09-30 | $88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | -$83.00K derived: sum of 2 quarters · filed 2018-11-05 | $205.00K 10-Q · filed 2018-11-05 | $634.00K derived: sum of 4 quarters · filed 2018-11-05 | |||||
| 2017-06-30 | -$171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $117.00K 10-Q · filed 2018-08-06 | $546.00K derived: sum of 3 quarters · filed 2018-08-06 | $820.00K derived: sum of 4 quarters · filed 2018-08-06 | |||||
| 2017-03-31 | $288.00K 10-Q · filed 2018-05-08 | $717.00K derived: sum of 2 quarters · filed 2018-05-08 | $991.00K derived: sum of 3 quarters · filed 2018-05-08 | $1.01M derived: sum of 4 quarters · filed 2018-05-08 | |||||
| 2016-12-31 | $429.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $703.00K derived: sum of 2 quarters · filed 2018-03-12 | $726.00K derived: sum of 3 quarters · filed 2018-03-12 | $652.00K 10-K · filed 2018-03-12 | |||||
| 2016-09-30 | $274.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $297.00K derived: sum of 2 quarters · filed 2017-11-07 | $223.00K 10-Q · filed 2017-11-07 | $99.00K derived: sum of 4 quarters · filed 2017-11-07 | |||||
| 2016-06-30 | $23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$51.00K 10-Q · filed 2017-08-07 | -$175.00K derived: sum of 3 quarters · filed 2017-08-07 | -$16.00K derived: sum of 4 quarters · filed 2017-08-07 | |||||
| 2016-03-31 | -$74.00K 10-Q · filed 2017-05-15 | -$198.00K derived: sum of 2 quarters · filed 2017-05-15 | -$39.00K derived: sum of 3 quarters · filed 2017-05-15 | ||||||
| 2015-12-31 | -$124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $35.00K derived: sum of 2 quarters · filed 2017-03-14 | $164.00K 10-K · filed 2017-03-14 | ||||||
| 2015-09-30 | $159.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $288.00K 10-Q · filed 2016-11-07 | |||||||
| 2015-06-30 | $129.00K 10-Q · filed 2016-08-10 | ||||||||
| 2014-12-31 | $150.00K 10-K · filed 2016-03-17 | ||||||||
| 2014-09-30 | $10.00K 10-Q · filed 2015-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |